ALTO INGREDIENTS INC (ALTO)

US0215131063 - Common Stock

1.64  +0.16 (+10.81%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to ALTO. ALTO was compared to 83 industry peers in the Chemicals industry. ALTO scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ALTO has a valuation in line with the averages, but it does not seem to be growing.



Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year ALTO has reported negative net income.
In the past year ALTO had a positive cash flow from operations.
ALTO had negative earnings in 4 of the past 5 years.
Of the past 5 years ALTO 4 years had a positive operating cash flow.

1.2 Ratios

ALTO has a Return On Assets of -8.98%. This is amonst the worse of the industry: ALTO underperforms 83.13% of its industry peers.
With a Return On Equity value of -14.20%, ALTO is not doing good in the industry: 78.31% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -8.98%
ROE -14.2%
ROIC N/A
ROA(3y)-2.1%
ROA(5y)-4.89%
ROE(3y)-3.86%
ROE(5y)-11.63%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Gross Margin of ALTO (0.86%) is worse than 90.36% of its industry peers.
In the last couple of years the Gross Margin of ALTO has declined.
The Profit Margin and Operating Margin are not available for ALTO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 0.86%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-39.9%
GM growth 5YN/A

More info and screens

4

2. Health

2.1 Basic Checks

ALTO does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ALTO has more shares outstanding
ALTO has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, ALTO has a worse debt to assets ratio.

2.2 Solvency

ALTO has an Altman-Z score of 0.32. This is a bad value and indicates that ALTO is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of ALTO (0.32) is worse than 83.13% of its industry peers.
The Debt to FCF ratio of ALTO is 24.84, which is on the high side as it means it would take ALTO, 24.84 years of fcf income to pay off all of its debts.
ALTO has a worse Debt to FCF ratio (24.84) than 61.45% of its industry peers.
A Debt/Equity ratio of 0.32 indicates that ALTO is not too dependend on debt financing.
ALTO has a better Debt to Equity ratio (0.32) than 72.29% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 24.84
Altman-Z 0.32
ROIC/WACCN/A
WACC9.05%

2.3 Liquidity

A Current Ratio of 3.22 indicates that ALTO has no problem at all paying its short term obligations.
The Current ratio of ALTO (3.22) is better than 85.54% of its industry peers.
A Quick Ratio of 2.15 indicates that ALTO has no problem at all paying its short term obligations.
ALTO's Quick ratio of 2.15 is amongst the best of the industry. ALTO outperforms 81.93% of its industry peers.
Industry RankSector Rank
Current Ratio 3.22
Quick Ratio 2.15

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 11.86% over the past year.
Looking at the last year, ALTO shows a very negative growth in Revenue. The Revenue has decreased by -21.54% in the last year.
The Revenue has been decreasing by -4.20% on average over the past years.
EPS 1Y (TTM)11.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%20%
Revenue 1Y (TTM)-21.54%
Revenue growth 3Y10.88%
Revenue growth 5Y-4.2%
Sales Q2Q%-20.84%

3.2 Future

ALTO is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 31.25% yearly.
The Revenue is expected to grow by 2.01% on average over the next years.
EPS Next Y4.54%
EPS Next 2Y59.25%
EPS Next 3Y42.43%
EPS Next 5Y31.25%
Revenue Next Year-23.39%
Revenue Next 2Y-9.31%
Revenue Next 3Y3.56%
Revenue Next 5Y2.01%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

ALTO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 7.84, the valuation of ALTO can be described as very cheap.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ALTO indicates a rather cheap valuation: ALTO is cheaper than 91.57% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of ALTO to the average of the S&P500 Index (23.78), we can say ALTO is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 7.84

4.2 Price Multiples

The rest of the industry has a similar Price/Free Cash Flow ratio as ALTO.
Industry RankSector Rank
P/FCF 37.47
EV/EBITDA N/A

4.3 Compensation for Growth

ALTO's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
ALTO's earnings are expected to grow with 42.43% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y59.25%
EPS Next 3Y42.43%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALTO!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ALTO INGREDIENTS INC

NASDAQ:ALTO (12/23/2024, 8:00:00 PM)

1.64

+0.16 (+10.81%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)11-06 2024-11-06/amc
Earnings (Next)N/A N/A
Inst Owners35.44%
Inst Owner Change-12.1%
Ins Owners4.81%
Ins Owner Change1.58%
Market Cap125.71M
Analysts82.5
Price Target4.59 (179.88%)
Short Float %1%
Short Ratio0.84
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)-9.9%
DP-3.37%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-80.53%
Min EPS beat(2)-212.04%
Max EPS beat(2)50.98%
EPS beat(4)1
Avg EPS beat(4)-98.66%
Min EPS beat(4)-218.63%
Max EPS beat(4)50.98%
EPS beat(8)2
Avg EPS beat(8)-128.62%
EPS beat(12)4
Avg EPS beat(12)-1041.47%
EPS beat(16)5
Avg EPS beat(16)-659.96%
Revenue beat(2)0
Avg Revenue beat(2)-4.01%
Min Revenue beat(2)-7.73%
Max Revenue beat(2)-0.28%
Revenue beat(4)1
Avg Revenue beat(4)-1.95%
Min Revenue beat(4)-8.37%
Max Revenue beat(4)8.57%
Revenue beat(8)4
Avg Revenue beat(8)-0.63%
Revenue beat(12)7
Avg Revenue beat(12)1.41%
Revenue beat(16)9
Avg Revenue beat(16)-0.86%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-355.56%
EPS NY rev (1m)0%
EPS NY rev (3m)-204.17%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-19.05%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-6.13%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 7.84
P/S 0.13
P/FCF 37.47
P/OCF 6.96
P/B 0.48
P/tB 0.49
EV/EBITDA N/A
EPS(TTM)-0.52
EYN/A
EPS(NY)0.21
Fwd EY12.75%
FCF(TTM)0.04
FCFY2.67%
OCF(TTM)0.24
OCFY14.37%
SpS13.08
BVpS3.44
TBVpS3.34
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.98%
ROE -14.2%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 0.86%
FCFM 0.33%
ROA(3y)-2.1%
ROA(5y)-4.89%
ROE(3y)-3.86%
ROE(5y)-11.63%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-39.9%
GM growth 5YN/A
F-Score6
Asset Turnover2.4
Health
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 24.84
Debt/EBITDA N/A
Cap/Depr 62.43%
Cap/Sales 1.47%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.22
Quick Ratio 2.15
Altman-Z 0.32
F-Score6
WACC9.05%
ROIC/WACCN/A
Cap/Depr(3y)116.21%
Cap/Depr(5y)75.44%
Cap/Sales(3y)2.2%
Cap/Sales(5y)1.51%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)11.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%20%
EPS Next Y4.54%
EPS Next 2Y59.25%
EPS Next 3Y42.43%
EPS Next 5Y31.25%
Revenue 1Y (TTM)-21.54%
Revenue growth 3Y10.88%
Revenue growth 5Y-4.2%
Sales Q2Q%-20.84%
Revenue Next Year-23.39%
Revenue Next 2Y-9.31%
Revenue Next 3Y3.56%
Revenue Next 5Y2.01%
EBIT growth 1Y30.66%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year101.5%
EBIT Next 3Y82.67%
EBIT Next 5Y57.75%
FCF growth 1Y-82.38%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-62.69%
OCF growth 3Y-32.52%
OCF growth 5Y69.59%